- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02533063
Semi-Recumbent Vibration Therapy in Older Adults
Study Overview
Detailed Description
There are four study visits; screening/baseline followed by eight weeks of training three times a week, visit 1 at eight weeks followed by 4 weeks of washout, Visit 2 at 12 weeks followed by eight weeks of training three times a week, and a final Visit 3 at 20 weeks.
At the screening visit, volunteers will be asked to perform tests included in the short physical performance battery (SPPB) (gait speed, chair rise, balance). If the participants score is ≤ 9 or ≤ 2 in any of the three tests included in the SPPB they will be eligible for the intervention phase. At the baseline visit several questionnaires will be obtained and participants then will proceed with muscle function tests (SPPB, jumping mechanography, grip strength, timed-up-and-go test).
Participants will then be randomized into one of two groups. The first group will receive vibration + loading treatment for the first 8 weeks, the second group will receive sham treatment (loading only). After 8 weeks both groups will go through a 4 week wash-out period and then crossover will occur. The first group will now receive sham treatment (loading only) while the second group will receive vibration + loading treatment. The participants will train for 10 minutes, 3 times a week, during the active 16 total weeks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53202
- Jewish Home and Care Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women age ≥ 70 years
- Able and willing to sign informed consent
- Able to stand without assistance
- Able and willing to train for 10 minutes, 3 times per week
- Total SPPB score of ≤ 9 or ≤ 2 in any of the three tests included in the SPPB
Exclusion Criteria:
- Cognitive impairment to the degree that it limits the ability of signing informed consent
- Unable to sit upright for 10 minutes
- History of injury or surgery within the prior six months which limits the ability to ambulate
- Major illness that might cause missed training sessions or visits.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Combination Treatment
In the "loading + vibration group" (intervention group), subjects will be seated in the VibeTech One system and vibratory acceleration will be 30Hz and the applied load will be 50% of body weight up to a device maximum applied load of 100 lbs.
Vibration intensity will initially be set to 0.2 g and will increase by 0.2 g every other week, as tolerated by the subject, and max out at 1.0 g.
|
Vibration Training The VibeTech One Rehab Chair allows vibration exercise while seated.
A force is applied on a footplate that simulates the weight of standing or partial bodyweight.
The participants will train for 10 minutes 3 days per week.
In the "loading + vibration group" (intervention group) vibratory acceleration will be 30Hz and the applied load will be 50% of body weight up to a device maximum applied load of 100 lbs.
Vibration intensity will initially be set to 0.2 g and will increase by 0.2 g every other week, as tolerated by the subject, and max out at 1.0 g.
|
|
Sham Comparator: Sham Treatment
In the "loading only" group (control group) participants will be seated in the vibration device (VibeTech One) and will experience loading of their leg muscles through the device.
|
Vibration Training The VibeTech One Rehab Chair allows vibration exercise while seated.
A force is applied on a footplate that simulates the weight of standing or partial bodyweight.
The participants will train for 10 minutes 3 days per week.
In the "loading + vibration group" (intervention group) vibratory acceleration will be 30Hz and the applied load will be 50% of body weight up to a device maximum applied load of 100 lbs.
Vibration intensity will initially be set to 0.2 g and will increase by 0.2 g every other week, as tolerated by the subject, and max out at 1.0 g.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight Corrected Jump Power Based on Participant's Jump on the Jump Force Plate
Time Frame: This was collected 4 times: Baseline, after 8 week loading/loading+ vibration training, after 4 week washout, after 8 week crossover training.
|
The primary aim of this pilot is to examine the effect of vibration therapy on muscle function.
Weight corrected jump power will be the main outcome variable.
Countermovement jumps are performed on a Leonardo force plate (Novotec Medical, Pforzheim, Germany) following standard procedures.
Jumping mechanography uses maximal countermovement jumps to quantitatively measure muscle strength in the legs.
Participants will be asked to perform three countermovement jumps.
Participants are asked to try to jump as high as possible using both legs.
Three jumps are performed; the jump with the highest jump height is used for analysis.
|
This was collected 4 times: Baseline, after 8 week loading/loading+ vibration training, after 4 week washout, after 8 week crossover training.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Grip Strength
Time Frame: Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.
|
Grip Strengthwas acquired using a JAMAR hand dynamometer in the routine clinical manner.
Measurements were recorded using participants' non-dominant hand and repeated 3 times to determine maximum grip strength.
|
Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.
|
|
Gait Speed
Time Frame: Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.
|
Gait speed will be measured by instructing participants to walk four meters at their normal pace; they are timed with a stopwatch.
This test will be repeated twice.
The walk performed in the least time will be utilized for scoring purposes.
|
Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.
|
|
Sway
Time Frame: Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.
|
Sway is assessed by having the participants stand with feet being placed side by side for ten seconds.
Participants will be wearing MobilityLabTM (APDM, Portland, OR) sensors on their chest, lower back, wrists and feet during these tests to collect computerized sway data.
|
Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.
|
|
Short Physical Performance Battery (SPPB)
Time Frame: Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.
|
The short physical performance battery (SPPB) consists of gait speed as determined by a four-meter walk, timed repeated chair rise and standing balance.
Gait speed will be measured by instructing participants to walk four meters at their normal pace; timed with a stopwatch and is repeated twice.
The walk performed in the least time will be utilized for SPPB scoring purposes.
The timed repeated chair rise has participants stand up from a chair five times without the use of their arms, if possible.
Time to complete five stands is measured.
Standing balance is assessed by having the participants stand in three positions of increasing difficulty for 10 seconds each.
Standardized instructions will be given to all participants and the test performed twice.
The SPPB will be conducted and scored in standard manner, score 0-12, with lower scores indicating mobility limitations.
Participants will be wearing MobilityLabTM sensors to collect computerized data for these tests.
|
Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.
|
|
Timed-Up-and-Go (TUG)
Time Frame: Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.
|
The Timed-Up-and-Go (TUG) test will be performed twice; participants will be seated in an armless chair, upon instruction, they will be asked to stand, which starts the timing, they will walk 3 meters past a mark on the floor at their normal pace, turn around and return to a full seated position, at which time the test will end.
|
Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.
|
|
Bioelectrical Impedance Spectroscopy (BIS)
Time Frame: Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.
|
An ImpediMed SFB7 device (Eight Mile Plains, Queensland, Australia) will be used to obtain these measurements.
Participants will be positioned supine for a minimum of 10 minutes prior to acquisition; adequate separation of their legs will be obtained to allow for accurate BIS measurement.
Measurements will be obtained by placing four EKG-like electrodes on the skin of the participant's hand, feet and knee.
Wires will be attached from the BIS device to these skin electrodes.
Painless electric waves will be sent through the tissues as noted above.
Each measurement lasts only a few seconds.
This method will generate measurements of lean mass.
|
Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence and Factors That Influence Adherence-Exercise Enjoyment
Time Frame: This was collected at the end of each 8 week intervention period.
|
Exercise enjoyment for each intervention was assessed using the validated questionnaire, "5-point Likert scale."
Response options include "strongly agree", "agree", "neutral", "disagree", "strongly agree".
|
This was collected at the end of each 8 week intervention period.
|
|
Adherence and Factors That Influence Adherence-Pain
Time Frame: This was collected before and after training during each of the 8 week interventions.
|
Self-reported pre- and post-training pain during the vibration intervention and control sessions were calculated as the mean for each participant using a validated questionnaire, "Comprehensive Pain Assessment Form" with scale from 0-10, 0 being no pain and 10 being severe pain.
|
This was collected before and after training during each of the 8 week interventions.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Bjoern Buehring, M.D., University of Wisconsin, Madison
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015-0480
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sarcopenia
-
University Hospital, BonnRecruiting
-
Cairo UniversityNot yet recruitingGeriatric SarcopeniaEgypt
-
Shanghai Yueyang Integrated Medicine HospitalShanghai University of Traditional Chinese Medicine; DongE E Jiao Coporation... and other collaboratorsNot yet recruiting
-
Assiut UniversityNot yet recruiting
-
TNF Pharmaceuticals, Inc.Not yet recruitingFrailty | Sarcopenia in Elderly | Frailty/Sarcopenia | Frailty in Older Adults
-
University of ExtremaduraCompletedSarcopenia in Elderly | Institutionalized Older Adults | HIITSpain
-
Medway NHS Foundation TrustNot yet recruitingFalls | Sarcopenia in ElderlyUnited Kingdom
-
University of Texas at AustinNot yet recruitingExercise Training and SarcopeniaUnited States
-
Animuscure Inc.Recruiting
-
West China HospitalNot yet recruitingSarcopenia in Elderly
Clinical Trials on VibeTech One
-
Harran UniversityCompletedPost Operative Pain | Chronic Apical Periodontitis of Pulpal OriginTurkey (Türkiye)
-
Universitair Ziekenhuis BrusselCompletedAdvance Care Planning | Ethnic Minorities | Moroccans | Advance Medical Directives | Muslims | Living WillBelgium
-
Addbio ABCompleted
-
University of EdinburghNHS LothianCompleted
-
Celal Bayar UniversityNot yet recruiting
-
Centre Antoine LacassagneRecruitingOsteosarcoma | Ewing Sarcoma | Chondrosarcoma | ChordomaFrance
-
Nourhan M.AlyCompletedClass II Dental CariesEgypt
-
Shepherd Center, Atlanta GACompletedAcquired Brain Injury | Family MembersUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...CompletedFoot Diseases | Complex Regional Pain Syndromes | Pain, Joint | Ankle DiseaseItaly
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedOverweight and ObesityUnited States